Dr Patrick Bowden

Welcome to Dr Patrick Bowden, a leading institution for comprehensive, patient-centred cancer care located at 32 Erin Street, Richmond, Australia. As a highly experienced doctor and consultant radiation oncologist, Dr Patrick Bowden remains at the forefront of cutting-edge radiation therapy techniques and clinical research.

With over 20 years of experience, Dr Bowden is dedicated to providing the highest standard of care for his patients. He is based at multiple reputable institutions including Icon Cancer Centre Richmond, Freemasons, Moreland, Mulgrave, and Canberra. Throughout his career, Dr Bowden has consistently embraced new technologies in radiation therapy treatment, making him a pioneer in the field.

One of Dr Bowden's areas of expertise is in intensity modulated radiation therapy (IMRT) and stereotactic radiation therapy for the treatment of early metastatic disease. His proficiency in these advanced techniques ensures that patients receive targeted and precise treatment, maximizing effectiveness while minimizing side effects.

Dr Patrick Bowden's impressive career began at the prestigious Peter MacCallum Cancer Centre, where he established himself as a respected radiation oncologist. In 2007, he became the director of the Tattersall’s Cancer Centre, the private arm of Peter MacCallum Cancer Centre. Subsequently, he was appointed as the inaugural Director of Epworth Radiation Oncology in 2011. During his tenure, he spearheaded the development of Australia's largest stereotactic radiation therapy service, which included a clinical trial institute and integrated oncology services at Epworth Freemasons. Dr Bowden's leadership also led to the establishment of the South West Regional Cancer Centre in Warrnambool in 2016. He played a vital role in the transition of Epworth Radiation Oncology to Icon Cancer Centre.

In addition to his clinical work, Dr Bowden is actively involved in education, medical leadership, research, and clinical trials. He served as a member of the Epworth Medical Advisory Committee from 2007 to 2016, contributing his expertise and insights. Outside of radiation oncology, Dr Bowden is the Chairman of Access Telehealth, a prominent organization that provides free consultations to patients in rural and remote areas.

Dr Bowden's commitment to advancing cancer treatments is evident through his participation in numerous clinical trials. He has acted as the principal investigator in key studies investigating radiation therapy treatments for lung, cervix, and prostate cancers. Notably, his world-leading study TRANSFORM, evaluating the efficacy of stereotactic radiation therapy for oligometastatic prostate cancer, was published in the International Journal of Cancer in July 2019. Another significant study, PINPOINT, which investigated the use of Calypso guidance beacons to reduce prostate radiation therapy side effects, was published in the World Journal of Urology in June 2021. Both of these Australian studies, supported by the Epworth Medical Foundation and EJ Whitten Foundation, were the world's largest clinical trials of their kind.

Dr Patrick Bowden's clinical experience spans across a broad range of solid tumor malignancies. He has a special interest in urological cancers, including prostate cancer, gastrointestinal cancer, central nervous system (CNS) tumors, and metastatic cancers. With his expertise and dedication to improving cancer care, Dr Bowden is a trusted and reliable choice for patients seeking comprehensive and personalized treatment.

Contact Dr Patrick Bowden today to schedule a consultation and experience exceptional cancer care tailored to your needs.